In this article, we will look at the 10 Best Stocks to Buy for the Next Decade.
A 10-year investing horizon shifts the conversation away from short-term noise toward something more durable: which businesses can keep growing, adapting, and compounding through different market environments. Franklin Templeton says markets are “transitioning from a narrow, liquidity-driven regime to one shaped by fundamentals, innovation, and active management,” which is another way of saying the next stretch may reward business quality more than simple momentum. For long-term investors, this shift is worth watching.
The institutional case for owning quality stocks over the long run is clear. Fidelity points investors toward “best-in-class companies” with “deep competitive moats” and says stocks with “long-term growth potential” can “compound earnings over time.” J.P. Morgan Asset Management adds that “High quality stocks are now priced at a discount,” and says the quality factor in U.S. markets is “more attractive than ever” outside unusually dislocated periods. Franklin Templeton makes the same argument from a longer-cycle perspective, emphasizing “high-quality growth companies with durable competitive advantages” and a process aimed at “sustainable alpha across cycles.” The best decade-long ideas are usually not the flashiest ones, but the companies with staying power, pricing power, and room to keep building value.
Against this backdrop, we will look at the 10 Best Stocks to Buy for the Next Decade.
Our Methodology
We used the Finviz screener to identify high-quality stocks that exhibited over 20% EPS annual growth over the last 5 years and are forecasted to grow EPS annually by over 20% in the next 5 years. We then limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
10. Eli Lilly and Company (NYSE:LLY)
On April 15, 2026, Eli Lilly and Company (NYSE:LLY) disclosed that the U.S. FDA had requested additional data related to potential liver injury associated with its newly approved obesity pill, along with post-marketing studies on cardiovascular risks and gastric emptying, according to a Reuters report. The agency also required a lactation study as part of its ongoing safety monitoring under the drug’s priority review approval. A Lilly spokesperson said there were no indications of liver damage in late-stage trials, adding that “The FDA approved Foundayo based on its review of data from the ATTAIN clinical program,” with post-approval requirements consistent with standard safety evaluation practices.
On April 12, 2026, Lilly reported topline results from the Phase 3 BRUIN CLL-322 trial evaluating Jaypirca, a non-covalent Bruton tyrosine kinase inhibitor, in combination with venetoclax and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma. The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival versus venetoclax and rituximab alone, with results consistent across key subgroups, including patients previously treated with a covalent BTK inhibitor. Overall survival data were not yet mature but trended in favor of the combination regimen, while the safety profile remained consistent with known profiles, and discontinuation rates were low across both arms. Lilly plans to present detailed data at a medical conference and submit findings to regulators for potential label expansion later this year.
On April 9, 2026, Morgan Stanley raised its price target on Eli Lilly to $1,327 from $1,313 and maintained an Overweight rating, reflecting model updates across its biopharma coverage ahead of Q1 earnings.
Eli Lilly and Company develops and markets pharmaceutical products globally.
9. Amphenol Corporation (NYSE:APH)
On April 14, 2026, UBS lowered its price target on Amphenol Corporation (NYSE:APH) to $170 from $174 and maintained a Buy rating. The firm said valuations have become more reasonable after turning cautious following Q4 results and 2026 guidance, which had highlighted limited upside and reliance on multiple expansion. UBS added that while demand concerns and potential production cuts could weigh on sentiment and near-term margins may face pressure from inflation, expectations have already reset lower, suggesting that even modest estimate cuts or reaffirmed guidance could be received positively by investors.
On April 8, 2026, Citi lowered its price target on Amphenol to $170 from $180 and kept a Buy rating. The firm noted that copper interconnect names have seen multiple compressions as the shift toward optical interconnect accelerates, but said the recent selloff in Amphenol presents an “attractive setup,” supported by constructive data center demand commentary during Q1.
Earlier, following its acquisition of the Connectivity and Cable Solutions business from Vistance Networks, Amphenol launched an open offer to acquire up to 1,196,000 equity shares of ADC India Communications, representing 26.0% of the company’s voting share capital, from public shareholders. The tendering period runs from April 2 to April 17, 2026, in accordance with SEBI regulations. The offer price is INR 1,233.59 per share, implying a total cash consideration of approximately INR 1.48B, assuming full acceptance. The open offer, which is not subject to a minimum acceptance threshold, was triggered by Amphenol’s indirect acquisition of control of the target company under a purchase agreement dated August 3, 2025, and follows the completion of the CCS acquisition, after which ADC India became an indirect majority-owned subsidiary.
Amphenol Corporation manufactures connectors and interconnect systems globally.
8. Carpenter Technology Corporation (NYSE:CRS)
On April 8, 2026, KeyBanc raised its price target on Carpenter Technology Corporation (NYSE:CRS) to $453 from $380 and maintained an Overweight rating. The firm cited findings from its proprietary Q1 Plane Chain survey, which indicated a meaningful step-up in OEM order activity as aerospace production recovery gains momentum. KeyBanc noted that supplier inventories are beginning to restock to support ongoing production ramps, while tight conditions in the aerospace and defense aftermarket are extending fleet life. The firm added that geopolitical tensions, including the Iran conflict, are supporting defense demand, though elevated fuel costs remain a key risk, potentially pressuring air travel demand and pushing airlines toward lower-cost alternatives.
Last month, Wells Fargo initiated coverage of Carpenter Technology with an Equal Weight rating and a $400 price target, warning that pricing gains may moderate due to increased capacity and a higher mix of fixed-price contracts, which could limit upside to future guidance.
Meanwhile, Susquehanna analyst Charles Minervino initiated coverage with a Positive rating and a $470 price target, highlighting Carpenter’s role as a supplier of specialized alloys into what it described as a “thriving” aerospace and defense market. The firm pointed to strong order activity, rising commercial aircraft production rates, and growing demand for advanced metallurgy, particularly in defense applications. Susquehanna also emphasized Carpenter’s solid balance sheet and liquidity position, which it believes support continued investment in growth, dividend increases, and share repurchases.
Carpenter Technology Corporation manufactures specialty metals and alloys for industrial applications worldwide.
7. First Solar, Inc. (NASDAQ:FSLR)
On April 8, 2026, Susquehanna lowered its price target on First Solar, Inc. (NASDAQ:FSLR) to $250 from $280 previously and maintained a Positive rating on the shares as part of a broader update to estimates ahead of Q1 earnings across its alternative energy coverage.
On April 6, 2026, Jefferies analyst Julien Dumoulin-Smith cut the firm’s price target on First Solar, Inc. to $187 from $205 previously and kept a Hold rating on the shares. The firm flagged rising concerns around inflationary logistics costs linked to the Middle East conflict, which could pressure near-term margins, and accordingly lowered its FY26 margin outlook for the company.
Last month, Guggenheim analyst Joseph Osha reduced the price target on First Solar, Inc. to $269 from $312 previously and maintained a Buy rating on the shares after updating estimates.
First Solar, Inc. develops and provides photovoltaic solar energy solutions.
6. Nucor Corporation (NYSE:NUE)
On April 15, 2026, Wells Fargo raised its price target on Nucor Corporation (NYSE:NUE) to $213 from $197 and maintained an Overweight rating, saying it has become more constructive on steel and aluminum heading into Q1 results, while taking a more selective stance on copper.
On April 14, 2026, JPMorgan raised its price target on Nucor to $212 from $198 and kept an Overweight rating as part of a broader Q1 preview for the North American steel group. The firm said a combination of “tight” supply and “mixed demand” conditions should remain supportive for the sector.
On March 31, 2026, Goldman Sachs analyst Nick Cash assumed coverage of Nucor with a Buy rating and a $210 price target, citing a bullish view on U.S. steel equities driven by sustained higher pricing tied to Section 232 tariffs, which have raised import costs and constrained supply. Goldman also pointed to above-average demand growth in infrastructure and pockets of strength in private non-residential construction, while favoring lower-beta companies with the potential to expand free cash flow and margins through product diversification and improving metal spreads.
Earlier in March, Nucor guided that first-quarter 2026 earnings are expected to increase across all three operating segments compared to Q4 2025, with the largest improvement in the steel mills segment due to higher average selling prices and volumes. The steel products segment is expected to benefit from increased volumes and stable pricing, while the raw materials segment is projected to post slightly higher earnings.
Nucor Corporation produces and sells steel and steel-related products.
5. Eldorado Gold Corporation (NYSE:EGO)
On April 15, 2026, BMO Capital analyst Brian Quast lowered the price target on Eldorado Gold Corporation (NYSE:EGO) to C$82 from C$98 and maintained an Outperform rating on the shares.
On March 25, 2026, Eldorado Gold entered into a project alliance through a Memorandum of Understanding with G Mining Services, forming a strategic engineering and construction partnership to support project delivery across its portfolio. Under the agreement, G Mining will provide services spanning early project definition, engineering support, constructability reviews, and planning, with the goal of improving project readiness, execution certainty, and capital efficiency. The collaboration will cover a range of assets, including Perama Hill; the Lamaque Complex, including the Sigma Mill expansion; Skouries, including mill start-up, ramp-up, and underground infrastructure; Olympias, including mill filtration modernization and facility upgrades; and McIlvenna Bay, including studies and potential initiatives to enhance throughput, value, and materials handling.
On March 24, 2026, Eldorado Gold announced leadership changes aimed at strengthening operational execution and project development. Simon Hille was appointed Executive Vice President and COO, overseeing global operations, projects, exploration, and health, safety, and sustainability. Hille, who joined the company in 2020, brings more than 30 years of experience in gold and base metals. The company also named Gordana Vicentijevic as Senior Vice President of Projects, effective May 4. She joins Equinox Gold with 28 years of experience in mining operations, project management, and engineering design and construction across mining, oil and gas, and chemical sectors.
Eldorado Gold Corporation operates mining and development projects across multiple regions.
4. ServiceNow, Inc. (NYSE:NOW)
On April 15, 2026, Truist lowered its price target on ServiceNow, Inc. (NYSE:NOW) to $125 from $175 and maintained a Buy rating ahead of quarterly results. The firm said it expects strong performance with potential upside to consensus estimates, supported by ServiceNow’s platform value proposition as enterprises consolidate vendors. Based on customer checks during the quarter, Truist believes ServiceNow is increasingly viewed as a key partner in enterprise AI roadmaps, with its incumbency positioning it well as it expands its agentic AI offerings.
On the same day, Oppenheimer lowered its price target on ServiceNow to $130 from $175 while maintaining an Outperform rating, citing lower valuation multiples across the software group. The firm said the upcoming Q1 update is unlikely to fully shift the current narrative around AI-driven disruption but noted that a more constructive trend in post-earnings estimate revisions could support the stock, particularly after a sharp year-to-date decline that has reset expectations.
Earlier in April, ServiceNow announced that its entire product portfolio is now AI-enabled, integrating AI, data connectivity, workflow execution, security, and governance across all offerings. The company also introduced its Context Engine, designed to connect relationships, policy, and decision history behind AI agent decisions, along with new Build Agent capabilities that allow developers to create and deploy solutions directly within the ServiceNow platform using existing tools.
ServiceNow, Inc. provides cloud-based workflow and enterprise software solutions globally.
3. Lam Research Corporation (NASDAQ:LRCX)
On April 15, 2026, Deutsche Bank analyst Melissa Weathers raised the price target on Lam Research Corporation (NASDAQ:LRCX) to $300 from $290 and maintained a Buy rating, citing expectations for a strong March quarter.
On April 1, 2026, Erste Group analyst Stephan Lingnau downgraded Lam Research Corporation to Hold from Buy, citing supply chain risks, including dependence on helium for tool production, which could pressure gross and operating margins.
Last month, Lam Research and IBM announced a five-year collaboration to develop new materials and fabrication processes to support sub-1nm logic scaling. The partnership will focus on advancing high-NA EUV lithography, as well as etch and deposition technologies for increasingly complex chip architectures. The two companies have collaborated for over a decade, contributing to earlier advances in 7nm, nanosheet, and EUV technologies, and now aim to extend scaling into the sub-1nm node.
Lam Research Corporation supplies semiconductor manufacturing equipment and services globally.
2. ASML Holding N.V. (NASDAQ:ASML)
On April 15, 2026, ASML Holding N.V. (NASDAQ:ASML) reported Q1 EPS of EUR 7.15, up from EUR 6.00 a year ago, on revenue of EUR 8.77B versus EUR 7.74B last year. The company said total net sales of approximately EUR 8.8B came in within guidance, while gross margin reached 53.0%, at the high end of its range. CEO Christophe Fouquet said demand trends remain strong, driven by AI-related infrastructure investments, with chip demand continuing to outpace supply and customers accelerating capacity expansion plans for 2026 and beyond. He added that order intake remains “very strong,” supported by increased short- and medium-term demand expectations, with ASML working closely with customers through both new system deliveries and upgrades to its installed base.
For Q2 2026, ASML expects revenue between EUR 8.4B and EUR 9.0B and gross margin between 51% and 52%, with R&D costs of around EUR 1.2B and SG&A expenses of about EUR 0.3B. For full-year 2026, the company now guides for total net sales of EUR 36B to EUR 40B and gross margin between 51% and 53%, noting that the guidance range reflects potential outcomes from ongoing export control discussions.
ASML also said it intends to declare a total dividend of EUR 7.50 per share for 2025, representing a 17% increase from the prior year. After accounting for three interim dividends of EUR 1.60 per share already paid, the company plans to propose a final dividend of EUR 2.70 per share at its annual general meeting.
ASML Holding N.V. provides advanced lithography systems used in semiconductor manufacturing.
1. Tesla, Inc. (NASDAQ:TSLA)
On April 15, 2026, TD Cowen lowered its price target on Tesla, Inc. (NASDAQ:TSLA) to $490 from $519 and maintained a Buy rating as part of a broader Q1 preview across the auto sector. The firm said automakers appear better positioned than suppliers to provide investors with outlook reassurance and maintain guidance credibility, adding that downside guidance risk looks limited. For Tesla, TD Cowen noted that a Q1 delivery miss and a “seemingly quiet quarter” on robotaxi developments have weighed on sentiment, though it sees a slightly positive setup heading into the earnings release.
Meanwhile, Barclays maintained an Equal Weight rating on Tesla with a $360 price target ahead of the Q1 report. The firm highlighted incremental spending requirements for Tesla’s physical AI initiatives, particularly the Terafab project, as a key focus for investors. Barclays estimates Terafab could reach mid-single-digit trillions of dollars if fully built out. While the firm does not expect capital expenditures to increase exponentially, it anticipates a further step-up from the roughly $20B level previously discussed. Barclays also attributed recent stock weakness to limited updates on robotaxi and Optimus progress, noting that while the pullback could create an opportunity for outperformance, commentary around higher capex may be viewed negatively by the market.
Earlier in April, Tesla reported first-quarter production of over 408,000 vehicles, deliveries of more than 358,000 vehicles, and deployment of 8.8 GWh of energy storage products. The company said it will release its full Q1 2026 financial results after market close on April 22.
Tesla, Inc. develops electric vehicles and energy systems globally.
READ NEXT: 10 Best Stocks That Beat Earnings Estimates and 10 Best 52-Week Low NASDAQ Stocks to Buy Now.
Hedge Fund Resource Center